Which is the best IVF/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial

DMR Dakhly, YA Bayoumi… - Gynecological …, 2016 - Taylor & Francis
This open label randomized study aims to define the best protocol to be used with growth
hormone in poor responders, with comparison performed to delineate which protocol offers …

The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: randomized control trial

DMR Dakhly, YA Bassiouny, YA Bayoumi… - European Journal of …, 2018 - Elsevier
Objective to detect the impact of growth hormone (GH) co-treatment to the long down
regulation protocol, on the outcomes of IVF/ICSI cycles in poor responders. Study Design …

[HTML][HTML] Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome …

YX Lee, MS Shen, CR Tzeng - Frontiers in Endocrinology, 2019 - frontiersin.org
Background: Growth hormone (GH) has long been used as adjuvant treatment in ovarian
stimulation for in vitro fertilization (IVF), especially in poor responder (PR) patients. However …

[HTML][HTML] Outcomes of poor responders following growth hormone co-treatment with IVF/ICSI mild stimulation protocol: a retrospective cohort study

K Chu, W Pang, N Sun, Q Zhang, W Li - Archives of Gynecology and …, 2018 - Springer
Purpose No research has studied the effect of GH co-treatment in mild stimulation protocol
for poor responders. We therefore conducted this retrospective analysis to assess the …

The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: a systematic …

XL Li, L Wang, F Lv, XM Huang, LP Wang, Y Pan… - Medicine, 2017 - journals.lww.com
Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …

Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis

KN Keane, JL Yovich, A Hamidi, PM Hinchliffe… - BMJ open, 2017 - bmjopen.bmj.com
Background Patients undergoing in vitro fertilisation (IVF) receive various adjuvant therapies
in order to enhance success rates, but the true benefit is actively debated. Growth hormone …

[HTML][HTML] Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology

M Eftekhar, A Aflatoonian, F Mohammadian… - Archives of gynecology …, 2013 - Springer
Purpose The incidence of poor ovarian response in controlled ovarian stimulation (COH)
has been reported in 9–24% of IVF-ET cycles. Growth hormone augments the effect of …

[HTML][HTML] Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A …

YA Bassiouny, DMR Dakhly, YA Bayoumi… - Fertility and sterility, 2016 - Elsevier
Objective To evaluate the effectiveness of the addition of growth hormone (GH) to the
antagonist protocol in IVF/intracytoplasmic sperm injection cycles in poor responders …

Low-dose growth hormone supplementation increases clinical pregnancy rate in poor responders undergoing in vitro fertilisation

K Lattes, M Brassesco, M Gomez… - Gynecological …, 2015 - Taylor & Francis
Poor ovarian response (POR) often means low success rates after in vitro fertilisation (IVF).
We aim to study the impact of a low-dose growth hormone (GH) supplementation in …

[HTML][HTML] Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis

M Cozzolino, GN Cecchino, G Troiano, C Romanelli - Fertility and sterility, 2020 - Elsevier
Objective To evaluate the effectiveness of growth hormone (GH) supplementation in
improving the in vitro fertilization (IVF) outcomes of poor responders. Design Systematic …